Edition:
India

Ucb SA (UCB.BR)

UCB.BR on Brussels Stock Exchange

70.40EUR
14 Jun 2019
Change (% chg)

€0.36 (+0.51%)
Prev Close
€70.04
Open
€70.04
Day's High
€70.52
Day's Low
€69.72
Volume
188,750
Avg. Vol
334,486
52-wk High
€81.48
52-wk Low
€65.38

About

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia,... (more)

Overall

Beta: 0.71
Market Cap(Mil.): €13,693.20
Shares Outstanding(Mil.): 194.51
Dividend: 1.21
Yield (%): 1.17

Financials

  UCB.BR Industry Sector
P/E (TTM): 16.75 32.88 37.45
EPS (TTM): 4.20 -- --
ROI: 9.95 12.53 12.16
ROE: 13.07 13.82 16.93

Earnings vs. Estimates